Recruiting

Fall Prevention Pathway

Sponsor:

Emory University

Code:

NCT07824141

Conditions

Old Age; Debility

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Accepted

Interventions

The Fall Prevention Pathway (FPP)

Study Details

Brief summary:

Falls are a leading cause of injury and loss of independence in older adults, with evidence supporting exercise-based interventions and remote monitoring as effective strategies for reducing fall risk. However, adherence and engagement with such programs remain significant challenges.

This study builds on prior research demonstrating the feasibility of digital health interventions in rehabilitation and extends it to a structured, remotely monitored Fall Prevention Pathway (FPP). Preliminary work in digital rehabilitation has shown positive engagement and clinical outcomes, supporting the need for further exploration of feasibility, adherence, and cost implications of remotely monitored fall prevention programs.

Conditions

Old Age; Debility

Study ID

NCT07824141

Start date

Sep 29, 2025

Status verified date

Sep, 2026

Completion date

Sep, 2028

Anticipated

Primary completion date

Sep, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Adults aged 65-85 years
  • Community-dwelling individuals classified as low to moderate fall risk based on standardized assessments, (i.e., the Stay Independent Screener)
  • Ability to ambulate independently or with a single-point cane
  • Willingness to participate in an 8-week intervention with remote monitoring
  • Access to a smartphone, tablet, or computer with internet connectivity
  • Ability to provide informed consent

Exclusion Criteria:

  • Severe cognitive impairment or a diagnosis of dementia that would affect adherence or ability to provide consent
  • Neurological or vestibular disorders (e.g., Parkinson's disease, multiple sclerosis, history of stroke with residual balance impairment)
  • Severe comorbidities that significantly impact mobility and function (e.g., recent orthopedic surgery, unstable cardiac conditions)
  • Significant visual or hearing impairments that prevent engagement with digital health interventions
  • Non-ambulatory or requiring assistance of another person for mobility

Study Design

Enrollment

50 participants

Anticipated

Intervention Model

Single group

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: The Fall Prevention Pathway (FPP)

Participants will be enrolled in an 8-week FPP intervention program. After completion of the 8-week FPP intervention, participants will undergo long-term follow-up assessments at 13 weeks (3 months) and 26 weeks (6 months) post-intervention. The follow-up assessments aim to assess sustained engagement, adherence, clinical outcomes, and fall incidence.

Interventions

The Fall Prevention Pathway (FPP)

The Fall Prevention Pathway (FPP) is a digital progression of exercises \& patient education delivered through a web platform designed to improve balance, boost confidence, and reduce fall risk. The FPP enrolls participants in a Medbridge Pathway and provides remote monitoring by a clinician who personalizes programs and provides verbal education to help reduce fall risk.

Primary outcome measure

  • Adherence to program [ Time Frame: At the end of the intervention (8 weeks) ]
  • Number of participants who complete the intervention [ Time Frame: 3 months and 6 months post-intervention ]

Central Contacts and Locations

Central contacts

Madeleine E. Hackney, Ph.D.

314-412-4852mehackn@emory.edu

Locations

Executive Park

Recruiting

Atlanta, Georgia, United States, 30329

Contacts

Madeleine E. Hackney, PhD

314-412-4852mehackn@emory.edu

More Information

Sponsor

Emory University

Last update posted

Sep 17, 2026

Last verified

Sep, 2026

Keywords

  • Older adults
  • Fall risk
  • Digital Program

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-18. This information was provided to ClinicalTrials.gov by Emory University on 2026-09-17.